Literature DB >> 31781941

Is metabolic syndrome responsible for the progression from NAFLD to NASH in non-obese patients?

Takumi Kawaguchi1, Takuji Torimura2.   

Abstract

Entities:  

Keywords:  Fibrosis; Metabolic abnormality; Steatohepatitis; Steatosis

Mesh：

Year:  2019        PMID： 31781941     DOI： 10.1007/s00535-019-01650-1

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  15 in total

1.  Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.

Authors:  Joo Hee Kwak; Dae Won Jun; Seung Min Lee; Yong Kyun Cho; Kang Nyeong Lee; Hang Lak Lee; Oh Young Lee; Ho Soon Choi; Byung Chul Yoon
Journal:  Clin Nutr       Date:  2017-08-30       Impact factor: 7.324

2.  Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.

Authors:  Anna Ludovica Fracanzani; Salvatore Petta; Rosa Lombardi; Giuseppina Pisano; Maurizio Russello; Dario Consonni; Vito Di Marco; Calogero Cammà; Laura Mensi; Paola Dongiovanni; Luca Valenti; Antonio Craxì; Silvia Fargion
Journal:  Clin Gastroenterol Hepatol       Date:  2017-05-26       Impact factor: 11.382

3.  Editorial: "Lean" NAFLD: Metabolic Obesity with Normal BMI… Is It in the Genes?

Authors:  Curtis K Argo; Zachary H Henry
Journal:  Am J Gastroenterol       Date:  2017-01       Impact factor: 10.864

4.  Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease.

Authors:  Fasiha Kanwal; Jennifer R Kramer; Srikar Mapakshi; Yamini Natarajan; Maneerat Chayanupatkul; Peter A Richardson; Liang Li; Roxanne Desiderio; Aaron P Thrift; Steven M Asch; Jinna Chu; Hashem B El-Serag
Journal:  Gastroenterology       Date:  2018-08-23       Impact factor: 22.682

5.  Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease.

Authors:  Vincent Wai-Sun Wong; Grace Lai-Hung Wong; Ruth Suk-Mei Chan; Sally She-Ting Shu; Bernice Ho-Ki Cheung; Liz Sin Li; Angel Mei-Ling Chim; Carmen Ka-Man Chan; Julie Ka-Yu Leung; Winnie Chiu-Wing Chu; Jean Woo; Henry Lik-Yuen Chan
Journal:  J Hepatol       Date:  2018-08-22       Impact factor: 25.083

6.  Prevalence and Severity of Nonalcoholic Fatty Liver Disease in Non-Obese Patients: A Population Study Using Proton-Magnetic Resonance Spectroscopy.

Authors:  Jeremy Lok Wei; Jonathan Chung-Fai Leung; Thomson Chi-Wang Loong; Grace Lai-Hung Wong; David Ka-Wai Yeung; Ruth Suk-Mei Chan; Henry Lik-Yuen Chan; Angel Mei-Ling Chim; Jean Woo; Winnie Chiu-Wing Chu; Vincent Wai-Sun Wong
Journal:  Am J Gastroenterol       Date:  2015-07-28       Impact factor: 10.864

7.  Characteristics of non-alcoholic steatohepatitis among lean patients in Japan: Not uncommon and not always benign.

Authors:  Maki Tobari; Etsuko Hashimoto; Makiko Taniai; Yuuichi Ikarashi; Kazuhisa Kodama; Tomomi Kogiso; Katsutoshi Tokushige; Nishino Takayoshi; Naotake Hashimoto
Journal:  J Gastroenterol Hepatol       Date:  2019-01-15       Impact factor: 4.029

Review 8.  Causes, Characteristics, and Consequences of Metabolically Unhealthy Normal Weight in Humans.

Authors:  Norbert Stefan; Fritz Schick; Hans-Ulrich Häring
Journal:  Cell Metab       Date:  2017-08-01       Impact factor: 27.287

9.  Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III.

Authors:  Preethi Srikanthan; Andrea L Hevener; Arun S Karlamangla
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

Review 10.  Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science.

Authors:  Gurmehr Brar; Hidekazu Tsukamoto
Journal:  J Gastroenterol       Date:  2019-01-14       Impact factor: 7.527
View more
  4 in total

1.  Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease.

Authors:  Yi-Ning Dai; Cheng-Fu Xu; Hong-Ying Pan; Hai-Jun Huang; Mei-Juan Chen; You-Ming Li; Chao-Hui Yu
Journal:  World J Clin Cases       Date:  2022-05-06       Impact factor: 1.534

2.  Dynamic co-expression modular network analysis in nonalcoholic fatty liver disease.

Authors:  Jing Zheng; Huizhong Wu; Zhiying Zhang; Songqiang Yao
Journal:  Hereditas       Date:  2021-08-21       Impact factor: 3.271

3.  Individuals with Metabolic Syndrome Show Altered Fecal Lipidomic Profiles with No Signs of Intestinal Inflammation or Increased Intestinal Permeability.

Authors:  Mia J Coleman; Luis M Espino; Hernan Lebensohn; Marija V Zimkute; Negar Yaghooti; Christina L Ling; Jessica M Gross; Natalia Listwan; Sandra Cano; Vanessa Garcia; Debbie M Lovato; Susan L Tigert; Drew R Jones; Rama R Gullapalli; Neal E Rakov; Euriko G Torrazza Perez; Eliseo F Castillo
Journal:  Metabolites       Date:  2022-05-11

Review 4.  MAFLD enhances clinical practice for liver disease in the Asia-Pacific region.

Authors:  Takumi Kawaguchi; Tsubasa Tsutsumi; Dan Nakano; Mohammed Eslam; Jacob George; Takuji Torimura
Journal:  Clin Mol Hepatol       Date:  2021-11-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.